-
Klotho Neurosciences Receives FDA Orphan Drug Designation for KLTO-202 in ALS
Jul 10 2025 -
Centivax Secures $45M for Universal mRNA Flu Vaccine
Jul 08 2025 -
Mustang Bio Receives FDA Orphan Drug Designation for MB-101 in Difficult-to-Treat Astrocytomas and Glioblastoma
Jul 08 2025 -
Lexeo Therapeutics Gains FDA Breakthrough Therapy Designation for AAV Gene Therapy in Friedreich Ataxia
Jul 07 2025 -
SCG Cell Therapy’s SCG101V Receives NMPA IND Clearance for Chronic Hepatitis B, First-Ever Cell Therapy for HBV
Jul 07 2025 -
Early Data for EsoBiotec’s In Vivo CAR-T Therapy (ESO-T01) in Multiple Myeloma
Jul 07 2025 -
JCR Pharmaceuticals Licenses JUST-AAV Capsid to Alexion for Genomic Medicines
Jul 07 2025 -
Private Biotech Funding Takes a Steep Dive in H1 2025
Jul 03 2025 -
4D Molecular Therapeutics Accelerates Phase 3 AAV Program for 4D-150 in Wet AMD
Jul 03 2025